India: GenomicsFund.com starts on high note.

STEVEN T. Newby, Chief Investment Officer of Genomics Fund.com (Nasdaq: GENEX), the world's first and only mutual fund specialising in investing in the dynamic, new genomics industry, reported that the Fund, launched March 1, gained 44.48 per cent in the quarter as of June 23, the Fund's first calendar quarter since its founding. In the same period, the S&P 500 was down 3.81 per cent and the NASDAQ Composite down 15.9 per cent.

Mr. Newby cautioned that the performance may not be indicative of future results, and that potential investors should read the prospectus carefully before investing. He suggested visiting the Fund's website for more information about the …